Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2011.
The company has posted a fall of 77.33% in its net profit after tax of Rs 13.14 crore for the quarter ended December 31, 2011 as compared to Rs 57.95 crore for the same quarter in the previous year. However, total income has increased by 27.26% from Rs 316.82 crore for Q3FY11 to Rs 403.17 crore in the quarter under review.
On the consolidated basis, the group has posted a drop of 46.70% in its net profit after tax to Rs 46.12 crore for the quarter ended December 31, 2011 as compared to Rs 86.53 crore in the same quarter last year. Total income of the company improved by 34.73% to Rs 1,041.85 crore for the quarter compared to Rs 773.28 crore in the quarter, year ago.
